BALIOPHARMA AG
4Patents
4Active
4Granted
41Portfolio score
Filing activity: Sep 16, 2011 → Nov 27, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8859739B2 | Anti-huTNFR1 antibody and methods of use thereof for treatment | Chemistry; Metallurgy | 17 | Active |
| US10689452B2 | Monovalent anti-huTNFR1 antibodies, encoding nucleic acids thereof and methods of treatment thereof | Chemistry; Metallurgy | 0 | Active |
| US11028178B2 | Method of treating nonalcoholic steatohepatitis by administering an antagonist human tumor necrosis factor receptor 1 (HUTNFR1) antibody | Chemistry; Metallurgy | 0 | Active |
| US10590202B2 | Recombinant bispecific antibody binding to CD20 and CD95 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.